AnaghaBangalore KumarMD

Dermatology Resident

Dr. Bangalore Kumar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Mayo Clinic College of Medicine and Science (Rochester)Residency, Dermatology, 2023
OtherClass of 2011

PubMed

27 citations
Premature Graying of Hair: Review with Updates.
Anagha Bangalore Kumar, Huma Shamim, Umashankar Nagaraju
International Journal of Trichology. 2018-09-01
153 citations
Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy.
Yiyi Yan, Anagha Bangalore Kumar, Heidi D. Finnes, Svetomir N. Markovic, Sean S. Park
Frontiers in Immunology. 2018-07-27
32 citations
Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients
Jesus Vera Aguilera, Jonas Paludo, Robert R. McWilliams, Henan Zhang, Ying Li
Melanoma Research. 2020-08-01

Journal Articles

The role of serum lactate dehydrogenase (LDH) level as a prognostic indicator in resected, high risk melanoma
Anagha Bangalore Kumar , Jesus Vera Aguilera , Ana Velazquez , Yiyi Yan , James Jakub , Jerry Brewer , Tina Hieken , Matthew Block , Robert McWilliams , Clark Otl..., Dermatologic Therapy, 1/30/2019
Treatment of morphea with hydroxychloroquine: A retrospective review of 84 patients at Mayo Clinic, 1996-2013
Anagha Bangalore Kumar, MBBS Elizabeth K. Blixt, MD Lisa A. Drage, MD Rokea A. el-Azhary, MD, PhD David A. Wetter, MD, Journal of the American Academy of Dermatology, 1/28/2019